Linde AG

  • WKN: 648300
  • ISIN: DE0006483001
  • Land: Deutschland

Nachricht vom 27.01.2016 | 13:00

Linde AG: Univation Technologies and The Linde Group to cooperate on advancing polyethylene plant and cracker integration

DGAP-News: Linde AG / Key word(s): Agreement

2016-01-27 / 13:00
The issuer is solely responsible for the content of this announcement.


Univation Technologies and The Linde Group to cooperate on advancing polyethylene plant and cracker integration

Houston/Munich, 27 January 2016 - Univation Technologies and The Linde Group's Engineering Division have entered into a cooperation agreement aimed at providing performance and cost efficiencies for the production of polyethylene resins. The parties expect that this exclusive partnership will deliver measurable benefits to resin producers globally. Under the agreement, Univation and Linde will work toward delivering streamlined technology, capital expense and operational expense reduction opportunities and improved quality in early stage design to ethylene cracker and polyethylene projects. The companies believe this will be valuable for both new construction projects as well as retrofit projects.

Dr Christian Bruch, member of the Executive Board of Linde AG and responsible for the company's engineering business, stated, "Our combination of technology and engineering, procurement and construction capabilities is a key driver to deliver competitive solutions to the petrochemical industry. We are excited to leverage the enormous potential synergies inherent in this close collaboration with Univation Technologies to deliver value to our existing and future customers."

Dr Steven F. Stanley, president of Univation Technologies, LLC, expressed the company's excitement to embark on this partnership with Linde. "As the leading polyethylene technology licensor around the world, we are constantly looking for ways to deliver more value for our licensees. This agreement with Linde allows us to take our solution-driven approach to the next level covering the entire UNIPOL(TM) PE Process platform including back-integration into cracker operations and improved economics for both new plant and retrofit projects."

This agreement is non-exclusive for the Engineering, Procurement and Construction (EPC) phase of UNIPOL(TM) PE Process projects.

About The Linde Group
In the 2014 financial year, The Linde Group generated revenue of EUR 17.047 bn, making it the largest gases and engineering company in the world with approximately 65,500 employees working in more than 100 countries worldwide. The strategy of The Linde Group is geared towards long-term, profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations around the globe. The company is committed to technologies and products that unite the goals of customer value and sustainable development.

For more information, see The Linde Group online at www.linde.com

About Univation Technologies
Univation Technologies is a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW) and the global leader in licensed polyethylene technology. Univation has a proven track record of delivering process, product, and catalyst technologies as well as related services to the global polyethylene industry for over 45 years. More than one-third of all HDPE and LLDPE resins produced globally is supplied by the industry-leading UNIPOL(TM) PE Process. Univation is also the world's leading manufacturer and supplier of conventional and advanced polyethylene polymerization catalysts designed specifically for the UNIPOL(TM) PE Process.

Further information:
The Linde Group
Stefan Metz
Phone: +49-89-35757-1322
E-mail: stefan.metz@linde.com

Univation Technologies
Duane Thompson
Phone +1-713-892-3668
E-mail: dthompson@univation.com



2016-01-27 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de



show this

Event im Fokus

62. m:access Analystenkonferenz

Datum: 13.10.2016
Zeit: 09:30 - 17:00 Uhr
Ort: Börse München
Karolinenplatz 6
80333 München

GBC im Fokus

Ergomed: Stabile Cashflows im Servicegeschäft, hohes Upside im Biotech-Portfolio

Die 1997 gegründete Ergomed plc (GB00BN7ZCY67) bietet für die pharmazeutische Industrie Dienstleistungen im Bereich der Entwicklung von pharmazeutischen Wirkstoffen an. Ergomed führt dabei klinische Entwicklungsprogramme für über 100 Kunden durch. Zusätzlich baut Ergomed ein Portfolio an Co-Entwicklungs-Partnerschaften mit Pharma- und Biotech-Unternehmen auf. Im Erfolgsfall ergibt sich hieraus ein hohes Gewinnpotenzial. Die Bewertung der Ergomed wurde auf Basis einer Sum-of-the-parts Analyse über das Servicegeschäft und Produktportfolio erstellt. Dabei haben wir einen fairen Wert für die Ergomed von 3,22 € pro Aktie ermittelt und vergeben das Rating KAUFEN.

Aktueller Webcast

Rocket Internet SE

H1 2016 Results for Rocket Internet and Selected Portfolio Companies

22. September 2016

Aktuelle Research-Studie

Golden Dawn Minerals Inc.

Original-Research: Golden Dawn Minerals Inc. (von Rockstone Research Ltd.): -

28. September 2016